![Daniel Camardo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Camardo
Director/Board Member at
CUE BIOPHARMA, INC.
Net worth: 585 112 $ as of 2026-07-30
Profile
Daniel A. Camardo is currently Director at CommunityHealth NFP and will be Director at Cue Biopharma, Inc. starting in 2026.
Formerly, Mr. Camardo was CEO, CFO, Secretary, Director & CAO at Athersys, Inc. from 2022 to 2023; Senior Director-US Commercial Operations at Astellas Pharma US, Inc. from 2003 to 2004; Vice President-Sales & Operations at Clarus Therapeutics, Inc. from 2014 to 2015; and President-US & Executive Vice President at Horizon Therapeutics Ltd. (Ireland) from 2020 to 2022.
Education includes undergraduate studies at Rochester Christian University and an MBA from Kellogg School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 0.52% | 2026-07-08 | 21,800 ( 0.52% ) | 585 112 $ | 2026-07-30 |
Daniel Camardo active positions
| Companies | Position | Start |
|---|---|---|
| CUE BIOPHARMA, INC. | Director/Board Member | 2026-05-29 |
CommunityHealth NFP
 CommunityHealth NFP Medical/Nursing ServicesHealth Services Provides free primary, specialty care, women's health, behavioral health, pharmacy and preventive healthcare services | Director/Board Member | - |
Former positions of Daniel Camardo
| Companies | Position | End |
|---|---|---|
| ATHERSYS, INC. | Chief Executive Officer | 2023-12-30 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 2022-01-31 |
Clarus Therapeutics, Inc.
 Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for men hypogonadism | Sales & Marketing | 2015-08-31 |
Astellas Pharma US, Inc.
 Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 2003-12-31 |
Training of Daniel Camardo
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for men hypogonadism | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Athersys, Inc.
 Athersys, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops novel and proprietary therapies | Health Technology |
CommunityHealth NFP
CommunityHealth NFP Medical/Nursing ServicesHealth Services Provides free primary, specialty care, women's health, behavioral health, pharmacy and preventive healthcare services | Health Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Daniel Camardo
